# A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

> **NCT00474526** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 4545 (actual)

## Conditions studied

- Meningitis, Meningococcal

## Interventions

- **BIOLOGICAL:** Meningococcal ACWY Conjugate Vaccine
- **BIOLOGICAL:** DTaP-IPV-HBV
- **BIOLOGICAL:** Hib
- **BIOLOGICAL:** Rotavirus
- **BIOLOGICAL:** Pneumococcal 7-valent Conjugate Vaccine
- **BIOLOGICAL:** HAV
- **BIOLOGICAL:** MMR-V
- **BIOLOGICAL:** DTaP

## Key facts

- **NCT ID:** NCT00474526
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-09
- **Final completion:** 2009-11
- **Target enrollment:** 4545 (ACTUAL)
- **Last updated:** 2014-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474526, "A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00474526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*